← Back to ACCRETION PHARMA LIMITED Overview

📊Financials 📈PE Ratio 🥧Shareholding 💰Dividend 📋Quarterly ⚖️Balance Sheet 💹P&L 🌊Cash Flow

ACCPLPharmaceuticals

ACCRETION PHARMA LIMITED — Financial Ratios & Key Metrics

₹63.55

-0.08%

P/E Ratio11.35xIndustry: 31.77x

ROE65.35%Return on equity

ROCE46.36%Return on capital

Debt/Equity0.17Low debt

💎

Valuation & Profitability

P/E Ratio

11.35x

Industry Average P/E

31.77x

Dividend Yield

0.00%

Market Cap

₹103.05 (Cr)

Sales Growth 5Y

N/A

Profit Growth 5Y

N/A

EPS Growth 5Y

N/A

OPM 5Y Avg

N/A

📉

Price Returns

1 Month

+54.76%

3 Months

+41.74%

6 Months

+41.42%

1 Year

+N/A

52W Low

₹54

Current

₹64

52W High

₹102

20% of 52-week range — Near lows

🔬

Technical Indicators

Neutral

Momentum is balanced — neither overbought nor oversold.

SMA 50

₹76

▼ Price below SMA 50 — Bearish

SMA 200

₹N/A

▼ Long-term downtrend

Volume Signal

249% of avg

Above average volume — strong conviction behind price move

Technical indicators are for educational purposes only. Not investment advice.

More on ACCRETION PHARMA LIMITED

Overview Financials PE History Shareholding Quarterly Balance Sheet P&L Cash Flow Pharmaceuticals Stocks Screener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.